Compared with the ischemia group, the IL-1β and IL-6 serum levels were significantly reduced in the ischemia + low-, medium- and high-dose NaHS groups; in the ischemia + medium- and high-dose NaHS groups the TNF-α level in the serum was significantly reduced. This evidence concerns the gene IL6 and ischemia.